Added value of digital PET in (re)staging patients with pancreatic cancer
Recruiting
- Conditions
- pancreatic cancer, response assesment, digital PET
- Registration Number
- NL-OMON22880
- Lead Sponsor
- Isala hospital, Zwolle, the Netherlands
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Histological or cytological confirmed malignant peri-ampullary tumour, resectable or borderline resectable, without evidence of distant metastases
-Inclusion in the PREOPANC-2 study
Exclusion Criteria
- Age < 18 years
- Incapacitated adults
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnostic outcome digital PET/CT
- Secondary Outcome Measures
Name Time Method Correlation FDG-uptake with Ca 19.9